159 related articles for article (PubMed ID: 19550080)
1. Predominant expression of mutated allele of the succunate dehydrogenase D (SDHD) gene in the SDHD-related paragangliomas.
Yamashita R; Usui T; Hashimoto S; Suzuki H; Takahashi M; Honkura K; Iwamoto K; Kodama E; Tagami T; Naruse M; Shimatsu A; Kaise K
Endocr J; 2009; 56(9):1129-35. PubMed ID: 19550080
[TBL] [Abstract][Full Text] [Related]
2. Nearly all hereditary paragangliomas in the Netherlands are caused by two founder mutations in the SDHD gene.
Taschner PE; Jansen JC; Baysal BE; Bosch A; Rosenberg EH; Bröcker-Vriends AH; van Der Mey AG; van Ommen GJ; Cornelisse CJ; Devilee P
Genes Chromosomes Cancer; 2001 Jul; 31(3):274-81. PubMed ID: 11391798
[TBL] [Abstract][Full Text] [Related]
3. A novel G106D alteration of the SDHD gene in a pedigree with familial paraganglioma.
Ogawa K; Shiga K; Saijo S; Ogawa T; Kimura N; Horii A
Am J Med Genet A; 2006 Nov; 140(22):2441-6. PubMed ID: 17041923
[TBL] [Abstract][Full Text] [Related]
4. Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas.
Benn DE; Croxson MS; Tucker K; Bambach CP; Richardson AL; Delbridge L; Pullan PT; Hammond J; Marsh DJ; Robinson BG
Oncogene; 2003 Mar; 22(9):1358-64. PubMed ID: 12618761
[TBL] [Abstract][Full Text] [Related]
5. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations.
Neumann HP; Pawlu C; Peczkowska M; Bausch B; McWhinney SR; Muresan M; Buchta M; Franke G; Klisch J; Bley TA; Hoegerle S; Boedeker CC; Opocher G; Schipper J; Januszewicz A; Eng C;
JAMA; 2004 Aug; 292(8):943-51. PubMed ID: 15328326
[TBL] [Abstract][Full Text] [Related]
6. High prevalence of SDHB mutations in head and neck paraganglioma in Belgium.
Persu A; Hamoir M; Grégoire V; Garin P; Duvivier E; Reychler H; Chantrain G; Mortier G; Mourad M; Maiter D; Vikkula M
J Hypertens; 2008 Jul; 26(7):1395-401. PubMed ID: 18551016
[TBL] [Abstract][Full Text] [Related]
7. [From gene to disease; from SDHD, a defect in the respiratory chain, to paragangliomas and pheochromocytomas].
Taschner PE; Bröcker-Vriends AH; van der Mey AG
Ned Tijdschr Geneeskd; 2002 Nov; 146(46):2188-90. PubMed ID: 12467161
[TBL] [Abstract][Full Text] [Related]
8. Loss of maternal chromosome 11 is a signature event in SDHAF2, SDHD, and VHL-related paragangliomas, but less significant in SDHB-related paragangliomas.
Hoekstra AS; Hensen EF; Jordanova ES; Korpershoek E; van der Horst-Schrivers AN; Cornelisse C; Corssmit EP; Hes FJ; Jansen JC; Kunst HP; Timmers HJ; Bateman A; Eccles D; Bovée JV; Devilee P; Bayley JP
Oncotarget; 2017 Feb; 8(9):14525-14536. PubMed ID: 28099933
[TBL] [Abstract][Full Text] [Related]
9. W43X SDHD mutation in sporadic head and neck paraganglioma.
Galera-Ruiz H; Gonzalez-Campora R; Rey-Barrera M; Rollón-Mayordomo A; Garcia-Escudero A; Fernández-Santos JM; DeMiguel M; Galera-Davidson H
Anal Quant Cytol Histol; 2008 Apr; 30(2):119-23. PubMed ID: 18561749
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas.
Baysal BE; Willett-Brozick JE; Lawrence EC; Drovdlic CM; Savul SA; McLeod DR; Yee HA; Brackmann DE; Slattery WH; Myers EN; Ferrell RE; Rubinstein WS
J Med Genet; 2002 Mar; 39(3):178-83. PubMed ID: 11897817
[TBL] [Abstract][Full Text] [Related]
11. Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes.
Benn DE; Gimenez-Roqueplo AP; Reilly JR; Bertherat J; Burgess J; Byth K; Croxson M; Dahia PL; Elston M; Gimm O; Henley D; Herman P; Murday V; Niccoli-Sire P; Pasieka JL; Rohmer V; Tucker K; Jeunemaitre X; Marsh DJ; Plouin PF; Robinson BG
J Clin Endocrinol Metab; 2006 Mar; 91(3):827-36. PubMed ID: 16317055
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of occult paragangliomas in asymptomatic carriers of SDHD and SDHB gene mutations.
Heesterman BL; Bayley JP; Tops CM; Hes FJ; van Brussel BT; Corssmit EP; Hamming JF; van der Mey AG; Jansen JC
Eur J Hum Genet; 2013 Apr; 21(4):469-70. PubMed ID: 22948026
[TBL] [Abstract][Full Text] [Related]
13. Disomy as the genetic underlying mechanisms of loss of heterozigosity in SDHD-paragangliomas.
Beristain E; Vicente MA; Guerra I; Gutiérrez-Corres FB; Garin I; Perez de Nanclares G
J Clin Endocrinol Metab; 2013 May; 98(5):E1012-6. PubMed ID: 23493432
[TBL] [Abstract][Full Text] [Related]
14. Increased prevalence of catecholamine excess and phaeochromocytomas in a well-defined Dutch population with SDHD-linked head and neck paragangliomas.
van Houtum WH; Corssmit EP; Douwes Dekker PB; Jansen JC; van der Mey AG; Bröcker-Vriends AH; Taschner PE; Losekoot M; Frölich M; Stokkel MP; Cornelisse CJ; Romijn JA
Eur J Endocrinol; 2005 Jan; 152(1):87-94. PubMed ID: 15762191
[TBL] [Abstract][Full Text] [Related]
15. The genetics of paragangliomas: a review.
Martin TP; Irving RM; Maher ER
Clin Otolaryngol; 2007 Feb; 32(1):7-11. PubMed ID: 17298303
[TBL] [Abstract][Full Text] [Related]
16. SDHx gene detection and clinical Phenotypic analysis of multiple paraganglioma in the head and neck.
Ding Y; Feng Y; Wells M; Huang Z; Chen X
Laryngoscope; 2019 Feb; 129(2):E67-E71. PubMed ID: 30484866
[TBL] [Abstract][Full Text] [Related]
17. Head and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patients.
Piccini V; Rapizzi E; Bacca A; Di Trapani G; Pulli R; Giachè V; Zampetti B; Lucci-Cordisco E; Canu L; Corsini E; Faggiano A; Deiana L; Carrara D; Tantardini V; Mariotti S; Ambrosio MR; Zatelli MC; Parenti G; Colao A; Pratesi C; Bernini G; Ercolino T; Mannelli M
Endocr Relat Cancer; 2012 Apr; 19(2):149-55. PubMed ID: 22241717
[TBL] [Abstract][Full Text] [Related]
18. High frequency of germline succinate dehydrogenase mutations in sporadic cervical paragangliomas in northern Spain: mitochondrial succinate dehydrogenase structure-function relationships and clinical-pathological correlations.
Lima J; Feijão T; Ferreira da Silva A; Pereira-Castro I; Fernandez-Ballester G; Máximo V; Herrero A; Serrano L; Sobrinho-Simões M; Garcia-Rostan G
J Clin Endocrinol Metab; 2007 Dec; 92(12):4853-64. PubMed ID: 17848412
[TBL] [Abstract][Full Text] [Related]
19. Impact of screening kindreds for SDHD p.Cys11X as a common mutation associated with paraganglioma syndrome type 1.
Peczkowska M; Erlic Z; Hoffmann MM; Furmanek M; Cwikla J; Kubaszek A; Prejbisz A; Szutkowski Z; Kawecki A; Chojnowski K; Lewczuk A; Litwin M; Szyfter W; Walter MA; Sullivan M; Eng C; Januszewicz A; Neumann HP
J Clin Endocrinol Metab; 2008 Dec; 93(12):4818-25. PubMed ID: 18826997
[TBL] [Abstract][Full Text] [Related]
20. Somatic and occult germ-line mutations in SDHD, a mitochondrial complex II gene, in nonfamilial pheochromocytoma.
Gimm O; Armanios M; Dziema H; Neumann HP; Eng C
Cancer Res; 2000 Dec; 60(24):6822-5. PubMed ID: 11156372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]